Your preferences have been updated successfully.
Top 30 Lists
Hedge fund buys 6.6% stake in Durham's BioCryst Pharma
A New York City hedge fund bought a 6.6 percent stake of a North Carolina pharmaceutical company, according to an SEC filing.
READ FULL INVESTMENT ARTICLE
In this article